Russians Ruslan Magomedov and Zubaira Tukhugov won’t be in the Octagon any time soon.
On Thursday, the Ultimate Fighting Championship’s drug-testing partner, the U.S. Anti-Doping Agency, announced that both fighters had accepted two-year suspensions stemming from failed drug tests.
Both fighters failed out-of-competition tests for the same substance, ostarine, a selective androgen receptor modulator designed to help muscle growth. Magomedov, 31, and Tukhugov, 27, both failed tested administered on Sept. 7, 2016, while Tukhugov failed an additional out-of-competition test on Oct. 29 of the same year.
Both suspensions are retroactive to Sept.